Financial Statements · Financial Reporting
PharmaSynth AS
Official identifier 11044101Record date 31 Dec 2021
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- AS
- Report status
- Registered
Dates
- Reporting year
- 2021
- Period start
- 1 Jan 2021
- Submitted date
- 2 Mar 2023
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 679,080 |
| Balance sheet | Cash and cash equivalents | 503,502 |
| Balance sheet | Current assets | 588,770 |
| Balance sheet | Current liabilities | 49,756 |
| Balance sheet | Equity | 629,324 |
| Balance sheet | Share capital at nominal value | 60,908 |
| Balance sheet | Non-current assets | 90,310 |
| Balance sheet | Retained earnings (loss) from previous periods | 314,506 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -18,936 |
| Income statement scheme 1 | Labour costs | -176,627 |
| Income statement scheme 1 | Revenue | 510,772 |
| Income statement scheme 1 | Annual period profit / loss | 247,819 |
| Income statement scheme 1 | Operating profit (loss) | 238,881 |
| Income statement scheme 1 | Profit (loss) before income tax | 247,819 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 314,506 |
| Note: Labour costs | Employees | 7 |
| Note: Labour costs | Labour costs | 176,627 |
Linked company
Company: PharmaSynth AS